© Copyright 2025 American Medical Association. All rights reserved.
| Short Descr | ADM SARSCOV2 50 MCG/.5 MLBST | Medium Descr | IMM ADMN SARSCOV2 50 MCG/0.5 ML BOOSTER DOSE 18+ | Long Descr | Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 50 mcg/0.5 mL dosage; booster dose, when administered to individuals 6 through 11 years and older | Status Code | Not Valid for Medicare Purposes | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Non-Covered Service, not paid under OPPS | Berenson-Eggers TOS (BETOS) | none | MUE | Not applicable/unspecified. |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 2025-01-01 | Deleted | First appearance of code deletion in codebook. |
| 2024-01-01 | Changed | First appearance of code change in Codebook. |
| 2024-01-01 | Note | First appearance of new AMA guideline changes in codebook. |
| 2023-11-01 | Deleted | Code deleted. To report administration of COVID-19 vaccine, use 90480. |
| 2023-04-18 | Note | Changes made to dosing information |
| 2023-04-18 | Note | These codes used in the guidelines are no longer authorized for use in the United States: 0091A, 0092A, 0094A, 91301, 91306 91309, 91311. |
| 2023-04-18 | Note | No longer authorized for use in the United States. |
| 2023-01-01 | Added | First appearance in codebook. |
| 2022-12-08 | Note | AMA Guideline changed. 91316 received FDA approval |
| 2022-11-16 | Note | AMA guideline changed to include 91316 effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-10-12 | Note | AMA Guideline changed. 91313 (12 yrs – 17 yrs) and 91314 both received FDA approval. |
| 2022-10-10 | Changed | Code description changed. |
| 2022-08-31 | Note | Changes made to vaccine name, product & dosing information, & patient age (6-11). |
| 2022-08-31 | Note | AMA Guideline changed. 91313 (18 yrs & older) received FDA approval immediately. |
| 2022-08-31 | Note | AMA guideline changed to include 91313, 91314 effective upon receiving emergency Use Authorization or approval from the FDA |
| 2022-07-06 | Changed | Code description changed. |
| 2022-06-17 | Note | AMA Guideline changed. 91311 received FDA approval. |
| 2022-06-17 | Note | AMA guideline changed to include 0091A, 0092A, 0093A. Published to website 2021-07-06 Received FDA approval effective retroactively to 2022-06-17. |
| 2022-05-19 | Note | AMA guideline changed to include 91311, effective upon receiving emergency Use Authorization or approval from the FDA |
| 2022-03-29 | Changed | Code description changed. |
| 2022-03-29 | Note | AMA guideline changed. 91309 received FDA approval. |
| 2022-03-29 | Added | Code received FDA approval. |
| 2022-03-07 | Added | Published on AMA website. Effective upon receiving emergency Use Authorization or approval from the FDA. |
| 2022-03-07 | Note | AMA guideline includes 91309 effective upon receiving Emergency Use Authorization or approval from the FDA. |
| 2022-03-07 | Note | AMA guideline includes 91301 & 91306: Published on website & received FDA approval prior to the addition of 0094A. |
Get instant expert-level medical coding assistance.